Drug Discovery World

JUNE 6, 2024

With the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting , taking place from 30 May to 3 June, the drug discovery announcements have been coming thick and fast, with many new cancer therapies making significant strides forward in our ability to treat the disease.

Drug Research 195

Drug Research Research Vaccine Clinical Trials 195

Drug Discovery World

MAY 28, 2024

According to a January 2024 report by market analysts Coherent Market Insights, the global bio-imaging market was estimated to be worth $5.74 The growth will in part by driven by an increase in the use of imaging modalities in drug research and development. How spatial biology is bettering our understanding of disease.

Drugs 130

Drugs Clinical Trials Marketing Disease 130

Vial

MAY 20, 2024

In this article, we will define preclinical and clinical CROs, as well as highlight the unique needs and challenges of these organizations in their respective stages of drug research. between 2024 and 2030. between 2024 and 2030. What is a Pre-Clinical CRO? billion in 2022 and is projected to reach US$10.2

Clinical Research 52

Clinical Research Research Clinical Trials Laboratories 52

Drug Discovery World

SEPTEMBER 26, 2024

The Drug Discovery in Scotland Forum showcased how Scotland is shaping drug discovery using approaches including traditional small molecules, therapeutic proteins, CRISPR/ RNAi and cell therapies, as well as how these are being used in 2D and 3D models.

Small Molecule 147

Small Molecule Drugs Therapies Disease 147

Drug Discovery World

AUGUST 8, 2023

Investment According to Invest India, the Indian pharmaceutical industry is expected to reach $65 billion by 2024 and to $130 billion by 20305. Outside of academia, there are institutions such as the CSIR- Central Drug Research Institute (CDRI), a multidisciplinary research laboratory in Lucknow 11.

Research 130

Research Pharmacy Pharmaceuticals Government 130

Agency IQ

JUNE 9, 2023

The problems: Although the current regulation stimulated orphan drug research, it didn’t do enough The regulation fostered development of medicines for rare diseases since implementation, but not enough. However, 95% of the over 6,000 recognized orphan diseases still have no treatment options.

Marketing 40

Marketing Biosimilars Regulations Drugs 40

Codon

JUNE 2, 2024

Without mouse models, we may never have developed polio and meningitis vaccines, organ transplants, GLP-1 drugs, gene therapies , or any other number of transformative treatments. Today, somewhere on the order of 30 million rodents are used yearly in biomedical research in the U.S. In a testimony in front of the U.S.

Laboratories 117

Laboratories Research Disease Science 117